The Prize Categories
There are five separate categories of awards, each carrying a £50,000 prize, plus an extra £50,000 in 2016 for both the Young Researcher (Asia) and Young Researcher (Americas) Prizes. In addition, the Black Box Prize offers the full £250,000 for a key breakthrough in human toxicity pathways research.
Science Prize
For individuals, research teams or institutions for work conducted on relevant toxicity pathways. Outstanding research producing an effective nonanimal safety test based on an approach other than toxicity pathways, where none existed before, may also be considered.
Training Prize
For individuals, teams or organisations involved in training others in non-animal methods.
Many established scientists may not have been trained in, or be aware of, alternative methods, while future scientists and students need to be provided with education in alternatives in order to be able to pursue further research in this area. Establishing training programmes and increasing capacity, whether as one-off workshops or ongoing programmes, can make a huge difference to this field.
This prize recognises the importance of dissemination of methods among commercial scientists, researchers and students. The criteria for training is broad, and includes training existing scientists a Kelly BéruBé is a member of the Lush Prize judging panel; b Craig Redmond is part of the Lush Prize management committee.
Young Researcher Prize
Open to keen young scientists (up to 35 years of age at the time of application) with a desire to fund the next stage of a career focused on an animal-test free future.
Because toxicology has for so long been centred on animal testing, many scientists with concerns about the use of animals are deterred from becoming toxicologists. Those who do enter the field can find that access to funding for working on non-animal tests can be a barrier. We want to change this, and to encourage young scientists to develop a career in toxicology without harming animals, by offering bursaries to allow them to advance in this area.
Lobbying Prize
This prize aims to reward the work of exceptional individuals, groups or organisations pushing for change, focusing on policy interventions promoting the use of alternatives. It is a One R prize, seeking projects working on replacement (rather than reduction and refinement), and avoids funding projects or initiatives linked to animal testing in other ways.
Scientific innovation needs to go hand-in-hand with policy change, to ensure that the end users of new testing approaches -industry and regulators -are receptive and responsive to the new methods.
Public Awareness Prize
Recognising that, despite years of campaigning, animal testing still continues, this prize is aimed at rewarding individuals or organisations raising public awareness of ongoing animal testing.
Partial legislative victories have led to the common misconception that animal testing, especially for cosmetics, no longer takes place. It is vital, therefore, that the public is reminded that this cruel and unscientific practice does continue in many areas of the world. Support is essential for public awareness activities to ensure that this issue remains high on the political agenda.
Black Box Prize
The Black Box Prize offers, in any one year, the full £250,000 Lush Prize fund for a key breakthrough in human toxicity pathways research.
The Lobbying, Public Awareness, Science and Training awards are all retrospective, in that they are for outstanding work and achievements in the 18 months preceding nomination. The Young Researcher Prize is different in that it is to fund future research.
For the Black Box Prize, research should have been completed and published within five years prior to the award. It is the only category for which nominations cannot be made. Allocation of a winner is at the discretion of the judges, based on both their knowledge of the current situation and research that the Prize Team carries out.
Young Researchers: The New Awards
With £10,000 on offer for up to five young scientists (under 35 years old) every year, this is a popular award in the Lush Prize. Unlike other categories, which are based on recent achievements, the Young Researcher Prize acts more like a grant, with nominees pitching their project seeking to replace animal testing. Between 2012 and 2015, 19 researchers have benefitted from £210,000 funding (four individuals in both 2012 and 2013, five in 2014 and six in 2015).
Although there have previously been two winners in this category from Brazil, it was recognised that scientists in certain parts of the world struggle to 'compete' with others who have greater access to advanced technologies, networking and moral support from supervisors and colleagues. So in 2016, boosted by £100,000 funding from Lush North America and Lush in Japan and South Korea, it was decided to launch regional awards: Young Researcher Lush Prize (Asia) and Young Researcher Lush Prize (Americas). These new regional versions of the Prize will enable us to tailor the communication about our particular brand of One R animal replacement science to audiences that may be less familiar with it. We began a series of outreach programmes to promote the regional awards and were delighted to award funding to three Asian young scientistsone each in China, South Korea and Japan. This process also provided useful feedback on the challenges that scientists face in these countries when wanting to work with in vitro methods. One winner told us how winning a Lush Prize gave her the motivation to continue, despite hostility from colleagues. Five successful Americas projects, all from North America, were funded. We recognise that fully reaching scientists in these regions will take some time, and we will extend outreach in Latin America.
Winners of both categories were presented with their awards at regional events. Awardees for the Americas prize were invited to a ceremony in Vancouver, attended by previous Young Researcher winners from Brazil. An event in Seoul was held for the Asian winners, preceded by an event where the public could learn about animal testing and alternatives in a fun and interactive way. The Lush Prize Team would like to thank Million, Daisaku, Maho, Brandi, Celeena and all their colleagues for their fantastic work in co-ordinating and supporting these regional awards.
Global Reach of the Prize
The Lush Prize is open to nominations from anywhere in the world, and has already awarded over £1.5 million to 76 winners in 26 countries. In 2016, there were 12 winners from nine countries, including our first winner from China (Vshine Animal Protection Association, who won the Public Aware ness Prize) and Iran (Iranian Anti-Vivisection Association, joint winner of the Training Prize). Nominations were also received for consideration from the Ukraine, Kenya, Belarus, Cyprus and Argentina.
In addition, judges are selected on the basis of their individual expertise, and it is also ensured that they represent a varied geographical range of affiliations. The eight judges in 2016 were based in Brazil, Canada, Denmark, UK and the USA.
The Lush Prize Team also attends conferences to present its work via oral and poster presentations. In 2016, these included the Pan American Conference for Alternative Methods (Baltimore, MA, USA), the European Congresses on Alternatives to Animal Testing (Linz, Austria) and the Asian Congress on Alternatives and Animal Use in the Life Sciences (Saga and Fukuoka, Japan).
Conference Theme: Regulating Chemical Safety -The Future For Animal Use
The Lush Prize annual conference, held in London on the day prior to the Awards Ceremony, was once again over-subscribed. With the impending REACH deadline, the conference theme, Regulating Chemical Safety -The Future for Animal Use, discussed how new regulatory requirements and a lack of 'validated' non-animal alternatives means that a short-term rise in animal use is being predicted by many. According to the conference programme:
"REACH presents many opportunities to promote the best in non-animal approaches to chemical safety assessment, from the use of available assays to data-waiving approaches. Yet, despite the REACH text itself mandating the avoidance of animal use wherever possible, the European Chemicals Agency (ECHA) confirmed that almost 5000 new animal tests had been conducted for REACH between 2007 and 2014, with the number of tests more than doubling since 2009. What are campaigners doing to address this problem? Are new non-animal tests coming through fast enough? Is there some other solution we haven't spotted yet?"
The morning panel heard from Humane Society International, Safer Medicines Trust, PETA International Science Consortium and the UK Health and Safety Executive. An afternoon session looked at the different rules globally and what, if any, collaborations were taking place to promote alternatives to animal use. Panellists consisted of the 1R Institute (Brazil), Physicians Committee for Responsible Medicine (USA), People for Animals (India), and Humane Society International (USA).
All winners were able to present their work during breakout sessions at the conference. In addition, we held a very successful winners session, which was an informal opportunity for everyone to sit down, discuss their work and explore networking opportunities. Unfortunately, Dr Roshanaie of the Iranian Anti-Vivisection Association (IAVA), a Training Prize winner, was unable to secure a visa to attend, but Nick Jukes of InterNICHE represented IAVA at the events.
Videos of most of the presentations by the prize winners are available on our website, http://lushprize.org/2016-prize/2016-conference/
Eligibility criteria
The Lush Prize is different to many other funding opportunities in the field of alternatives to animal testing in that it is a One R rather than Three Rs prize: we only fund projects that work to replace, rather than reduce or refine, animal experiments.
Non-animal research in this sense means no use of non-human animals (including all vertebrates and invertebrates) or primary animal cells, embryos, tissues, organs and sera. Human biology-based approaches are strongly encouraged, although the use of established cell lines of nonhuman animal origin would not necessarily be excluded.
Any nominees for the three science-based categories are asked to clarify whether they have conducted any animal-based research in recent years and this is taken into account by the judges.
For the new Young Researcher prizes in Asia and the Americas, it is recognised that meeting all of these criteria is more of a challenge and many applicants may not yet be working in a completely animal-free laboratory; the judges do take this into account. However, the winners still need to commit to using Lush Prize funds in a way that complies with the eligibility criteria.
Transparency
Although funded entirely by Lush Cosmetics, the management of the Prize is conducted by Ethical Consumer Research Association. ECRA is an independent, not-for-profit, multi-stakeholder co-operative with open membership, conducting research with the aim of making global business more sustainable through consumer pressure.
The independent panel of judges chooses the winners; neither the Lush Prize, ECRA nor Lush Cosmetics have any say in this decision. The judges are selected for their expertise in the areas of animal experimentation, alternatives, science, regulatory processes, public awareness and animal protection. We aim to have judges representing various geographical areas, which allows the panel to greater understand the research and campaigns, as well as the quality of nominations, in those regions. Crucially, it encourages more nominations from countries previously under-represented.
It is inevitable that nominations are occasionally submitted on behalf of organisations/science teams for which the judges work, or students who they supervise. In these cases, the individual judge leaves the room and takes no part in discussions about that nomination. Impartiality is crucial for both the success and transparency of the Lush Prize.
Comments and feedback
We welcome any comments on how we can improve the Lush Prize. Although we already conduct evaluative surveys with prize winners and those attending the conference, we appreciate any additional feedback. If you would like to speak to us, please contact Craig Redmond (contact details below). 000) . Dr Zink and Dr Loo have developed animal-free methods that can accurately predict the toxic effects of chemicals on the human kidney. The approaches combine human cell models, including stem cell-based models, with automated image analysis software and toxicity prediction by machine learning. The toxicity of different chemicals -such as drugs, industrial chemicals and natural compounds -to renal proximal tubular cells, could be predicted with an accuracy of 80-90%. This technology can also be applied to other human organs such as the liver, lung and blood vessels.
Lush Prize winners

Young Researcher (Asia)
-Mijoo Kim, Yonsei University, South Korea. For the development of in vitro models for testing dental materials.
-Kumiko Tatsumi, Osaka City University, Japan. For the development of an in vitro system for evaluating hepatotoxicity.
-Yu Chen, The Center for Alternatives Research & Evaluation, China. For research into alternative tests for hygiene toxicology.
Young Researcher (Americas)
-Kambez Hajipouran Benam, Harvard University, USA. For engineering a smoking lung chip to replace animals in inhalation toxicology.
-Daria Filonov, Creative Scientist Inc., USA.
For the development of a cardiovascular disease screening platform with human primary endothelial colony forming cells that could form the basis of personalised toxicological screening.
-Nicole C. Kleinstreuer, National Institute of Environmental Health Sciences, USA. For work in computational toxicology and the Tox21 high-throughput screening (HTS) programme, applying computational modelling strategies to address many different endpoints.
-Kimberly Norman, Institute for In Vitro Sciences, USA. For optimising animal-free methods to distinguish skin sensitisers from respiratory sensitisers by using the Direct Peptide Reactivity Assay (DPRA).
-Yu Shrike Zhang, Brigham and Women's Hospital, USA. For a project based on the development of the multi-material bioprinting system for engineering biomimetic human tissue and organ models.
Young Researcher (Rest of the World)
-Giorgia Pallocca, University of Konstanz, Germany. For a project to predict the toxic effects of environmental pollutants and clinical drugs affecting the neural crest.
-Pranjul Shah, University of Luxembourg, Luxembourg. For the further design and application of a credit card-sized system that is capable of reproducing any interface of the human body where bacteria reside and interact with tissues, such as in the gut, lung, skin, etc.
-Eleftheria Pervolaraki, University of Leeds, UK. For a project to further understand human heart development by using human volunteers, their data sets and computational modelling. This will answer how babies get arrhythmias in utero and how these defects may lead to sudden death.
-Katherine Chapman, Swansea University, UK. For a PhD project that aims to improve cellbased tests for DNA damage by using longerterm chemical treatments and lower doses, 3-D skin models and human cells. This could contribute to the replacement of the two-year rodent cancer bioassay.
-Antje Appelt-Menzel, University Hospital Würzburg, Germany. For a PhD project to develop an improved human in vitro model of the healthy blood-brain barrier (BBB) by using a human induced pluripotent stem cell (hiPSC) source.
Training
-Kirkstall Ltd, UK (£25,000). Kirkstall aims to change researchers' perspectives on animal replacement and in vitro testing through training workshops that provide an introduction to the theory and practice of advanced cell culture techniques.
-Iranian Anti-Vivisection Association, Iran (£25,000). Despite the challenging environment of working in Iran, IAVA has been working with universities for over six years, meeting with deans, teachers and students nationwide to demonstrate and introduce humane alternatives. 
Lobbying
A Tribute to Andrew Tyler
When the Lush Prize was launched in 2012, one of the first steps was to set up an expert panel of judges who could also act as an advisory board.
There was no doubt that one person we wanted as a judge, who had consistently and expertly highlighted the moral outrage, as well as the scientific invalidity of experimenting on animals, was Andrew Tyler. Since 1995, Andrew had been the Director of Animal Aid, Europe's largest animal rights organisation. With a background in journalism -first for various music press then, as a freelance writer for The Observer, The Independent, The Guardian and others -Andrew had a commitment to strong research and investigations underpinning Animal Aid's work.
Andrew remained a judge for the first three years of the Lush Prize, with an unwavering commitment to supporting an end to animal experi-ments. In an interview in 2012, he discussed the challenges ahead and said he had hope that the public would "wake up" to what was happening in labs, remarking: "We have to describe the future that we want".
The whole Lush Prize Team was devastated to hear that Andrew had passed away on 28 April 2017. He was one of the most dedicated, compassionate and outspoken defenders of animals the movement has seen, and our hearts go out to his wife Sara, stepson Davey, and the Animal Aid 'family'. Cardiff CF10 3AX  UK  E 
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